The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMGEN INC | COM | 031162100 | 44,081 | 212,655 | SH | SOLE | 212,655 | 0 | 0 | ||
| AVANOS MEDICAL INC | COM | 05350V106 | 5,087 | 74,258 | SH | SOLE | 74,258 | 0 | 0 | ||
| DIGIRAD CORP | COM | 253827109 | 499 | 332,609 | SH | SOLE | 332,609 | 0 | 0 | ||
| ELANCO ANIMAL HEALTH INC | COM | 28414H103 | 6,978 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 43,686 | 511,186 | SH | SOLE | 511,186 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 41,681 | 539,836 | SH | SOLE | 539,836 | 0 | 0 | ||
| INVACARE CORP | COM | 461203101 | 15,645 | 1,075,263 | SH | SOLE | 1,075,263 | 0 | 0 | ||
| MCKESSON CORP | COM | 58155Q103 | 51,504 | 388,268 | SH | SOLE | 388,268 | 0 | 0 | ||
| MERCK & CO. INC. | COM | 58933Y105 | 36,244 | 510,908 | SH | SOLE | 510,908 | 0 | 0 | ||
| ORTHOFIX MEDICAL INC | COM | 68752M108 | 17,904 | 309,708 | SH | SOLE | 309,708 | 0 | 0 | ||
| RTI SURGICAL INC | COM | 74975N105 | 20,081 | 4,462,439 | SH | SOLE | 4,462,439 | 0 | 0 | ||
| SIEMENS HEALTHINEERS AG | COM | D6T479107 | 17,375 | 396,406 | SH | SOLE | 396,406 | 0 | 0 | ||
| SHIRE PLC-ADR | COM | 82481R106 | 26,211 | 144,596 | SH | SOLE | 144,596 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP | COM | 91307C102 | 62,163 | 486,103 | SH | SOLE | 486,103 | 0 | 0 | ||